A clinical study to evaluate the effect of Indian Dammer Resin (Shorea robusta) in women with abnormal uterine bleeding.

A randomised controlled clinical trial to evaluate the effect of Shala Niryasa in the management of Asrigdara (AUB). - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104281

Enrollment

Registered

2026-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N921- Excessive and frequent menstruation with irregular cycle Health Condition 3: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining of excessive bleeding (more than 80ml) per cycle and Increased duration of bleeding (more than 7 days) as a cardinal symptom.

Exclusion criteria

Exclusion criteria: Use of IUCD. Patient with ongoing treatment of systemic disease like diabetes, hypertension. Uterine and pelvic pathology like polyps, fibroids, adenomyosis. Hypo/Hyperthyroidism. Non- Menstrual causes for bleeding (foreign body, genital malignancy, abortion, post-coital). Pregnancy. Hb more than 9gm per dl. PCOS. Post - menopausal bleeding. Peri-menarchial adolescents.

Design outcomes

Secondary

Measure	Time frame
Reduction in severity of associated symptoms of Asrigdara, such as: Angamarda (body ache) Vedana (pain) Daha (burning sensation)Timepoint: 90 days	—

Primary

Measure	Time frame
Reduction in quantity of menstrual bleeding Reduction in duration of menstrual bleeding (number of bleeding days)Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Venkata Rathnakar

Sri Jayendra Saraswathi Ayurveda College and Hospital

drlrathnakar@sjsach.org.in9840340826

Outcome results